Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Nason

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Virology|October 23, 2009
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunizationCheng Cheng, Jason G D Gall, Martha Nason, et al.
Journal of Virology|November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral ReservoirsDiane L Bolton, Amarendra Pegu, Keyun Wang, et al.
The Journal of Infectious Diseases|April 18, 2026
Bacterial dysbiosis, cervicovaginal human papillomaviruses and inflammation persist in women living with HIV-1 after a year of antiretroviral treatmentAndrea Lisco, Alessandra Borgognone, Christophe Vanpouille, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 29, 2020
Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern MexicoSally Hunsberger, Ana M Ortega-Villa, John H Powers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, UgandaJessica L Prodger, Jun Lai, Steven J Reynolds, et al.
The Journal of Infectious Diseases|March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trialJulie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.
Plos Pathogens|June 5, 2010
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite controlAdam R Hersperger, Florencia Pereyra, Martha Nason, et al.
Vaccine|October 1, 2008
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trialJulie E Martin, Mark K Louder, LaSonji A Holman, et al.
Journal of Virology|March 16, 2012
Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infectionTakuya Yamamoto, Matthew J Johnson, David A Price, et al.
Plos Pathogens|August 25, 2018
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replicationKrystelle Nganou-Makamdop, James M Billingsley, Zachary Yaffe, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Virology|October 23, 2009
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunizationCheng Cheng, Jason G D Gall, Martha Nason, et al.
Journal of Virology|November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral ReservoirsDiane L Bolton, Amarendra Pegu, Keyun Wang, et al.
The Journal of Infectious Diseases|April 18, 2026
Bacterial dysbiosis, cervicovaginal human papillomaviruses and inflammation persist in women living with HIV-1 after a year of antiretroviral treatmentAndrea Lisco, Alessandra Borgognone, Christophe Vanpouille, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 29, 2020
Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern MexicoSally Hunsberger, Ana M Ortega-Villa, John H Powers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, UgandaJessica L Prodger, Jun Lai, Steven J Reynolds, et al.
The Journal of Infectious Diseases|March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trialJulie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.
Plos Pathogens|June 5, 2010
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite controlAdam R Hersperger, Florencia Pereyra, Martha Nason, et al.
Vaccine|October 1, 2008
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trialJulie E Martin, Mark K Louder, LaSonji A Holman, et al.
Journal of Virology|March 16, 2012
Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infectionTakuya Yamamoto, Matthew J Johnson, David A Price, et al.
Plos Pathogens|August 25, 2018
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replicationKrystelle Nganou-Makamdop, James M Billingsley, Zachary Yaffe, et al.
Pageof 8